- Home
- BLNK vs RVNC Comparison
BLNK vs RVNC Comparison
Compare BLNK & RVNC Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- BLNK
- RVNC
- Stock Information
- Founded
- BLNK 2009
- RVNC 1999
- Country
- BLNK United States
- RVNC United States
- Employees
- BLNK N/A
- RVNC N/A
- Industry
- BLNK Industrial Specialties
- RVNC Biotechnology: Pharmaceutical Preparations
- Sector
- BLNK Consumer Discretionary
- RVNC Health Care
- Exchange
- BLNK Nasdaq
- RVNC Nasdaq
- Market Cap
- BLNK 295.1M
- RVNC 546.4M
- IPO Year
- BLNK N/A
- RVNC 2014
- Fundamental
- Price
- BLNK $2.11
- RVNC $5.28
- Analyst Decision
- BLNK Strong Buy
- RVNC Buy
- Analyst Count
- BLNK 7
- RVNC 10
- Target Price
- BLNK $5.79
- RVNC $10.86
- AVG Volume (30 Days)
- BLNK 4.4M
- RVNC 1.8M
- Earning Date
- BLNK 11-07-2024
- RVNC 11-06-2024
- Dividend Yield
- BLNK N/A
- RVNC N/A
- EPS Growth
- BLNK N/A
- RVNC N/A
- EPS
- BLNK N/A
- RVNC N/A
- Revenue
- BLNK $156,918,000.00
- RVNC $251,178,000.00
- Revenue This Year
- BLNK $6.96
- RVNC $20.36
- Revenue Next Year
- BLNK $31.64
- RVNC $31.66
- P/E Ratio
- BLNK N/A
- RVNC N/A
- Revenue Growth
- BLNK 66.29
- RVNC 40.23
- 52 Week Low
- BLNK $1.53
- RVNC $2.30
- 52 Week High
- BLNK $4.66
- RVNC $9.75
- Technical
- Relative Strength Index (RSI)
- BLNK 62.35
- RVNC 43.99
- Support Level
- BLNK $1.63
- RVNC $5.10
- Resistance Level
- BLNK $2.14
- RVNC $5.43
- Average True Range (ATR)
- BLNK 0.12
- RVNC 0.17
- MACD
- BLNK 0.04
- RVNC 0.02
- Stochastic Oscillator
- BLNK 94.12
- RVNC 64.29
About BLNK Blink Charging Co.
Blink Charging Co is an owner, operator, and provider of electric vehicle (EV) charging services. The company offers both residential and commercial EV charging equipment, enabling EV drivers to easily recharge at various location types. The company's business is the sale and distribution of electric vehicle charging equipment and its associated revenues earned from customers and/or Property Partners who use equipment connected to its network. It earns majority revenue from U.S.A.
About RVNC Revance Therapeutics Inc.
Revance Therapeutics Inc is a biotechnology company focused on aesthetic and therapeutic offerings, including its neuromodulator product, DaxibotulinumtoxinA for Injection. The company has launched a prestige aesthetics portfolio, which includes the RHA Collection of dermal fillers and the HintMD platform. Its main products include DaxibotulinumtoxinA for Injection and DaxibotulinumtoxinA for Injection Aesthetics. The operating business segments are the Product and the Service Segment. The Products segment generates maximum revenue and is engaged in the research and development of aesthetic and therapeutic products.